Judith Jaffe MS Center & Weill Cornell Imaging at NYP NMSS Walk Team,
" These findings suggest that currently approved oral MS therapies and structurally related compounds possess antibacterial…
" These findings suggest that currently approved oral MS therapies and structurally related compounds possess antibacterial…
https://www.ncbi.nlm.nih.gov/pubmed/28180112
Currently approved oral MS therapies possess antibacterial properties that may alter the gut microbiota and, for example…